Document is current
Any future updates will be listed below
-
Authors
Shim, Susy
Reinacher-Schick, Anke
Kraeft, Anna-Lena
Per Pfeiffer,
Tarpgaard, Line Schmidt
Ettrich, Thomas Jens
Kestler, Angelika
Christensen, Signe
Jandu, Haatisha
Nawabi, Mubeen
Roest, Nicklas Lindland
Damstrup, Lars
Vestlev, Peter Michael
Brünner, Nils
Stenvang, Jan
Ladekarl, Morten
-
Funding
Funding for this research was provided by:
Aalborg University Hospital
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 10 March 2025
First Online: 24 April 2025
Declarations
:
: H.J., M.N., N.L.R., P.M.V., and N.B. are employees at Scandion Onoclogy. J.S. is co-founder, CSO, employee and shareholder at Scandion Oncology. L.D. is employee and shareholder at Scandion Oncology. M.L. received an unrestricted grant from Scandion Oncology A/S, Denmark. Honorary lecture for Astra Zeneca, Denmark. All others declare no conflicts of interest.
